$2.32 Billion is the total value of HealthCor Management, L.P.'s 68 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 78.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDT | Buy | MEDTRONIC PLC | $158,339,000 | +106.2% | 1,530,580 | +149.9% | 8.62% | +160.1% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $112,514,000 | -46.9% | 1,804,550 | -49.7% | 6.12% | -33.1% |
| BIIB | Sell | BIOGEN INC | $108,780,000 | -17.7% | 453,400 | -2.9% | 5.92% | +3.8% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $89,685,000 | -35.9% | 832,270 | -34.9% | 4.88% | -19.2% |
| NVST | Sell | ENVISTA HOLDINGS CORPORATION | $74,019,000 | -21.3% | 1,642,680 | -27.0% | 4.03% | -0.8% |
| NTRA | Sell | NATERA INC | $70,315,000 | -29.7% | 752,920 | -16.1% | 3.83% | -11.4% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $69,225,000 | -35.4% | 520,920 | -41.9% | 3.77% | -18.5% |
| THC | Sell | TENET HEALTHCARE CORP | $63,896,000 | -11.3% | 782,180 | -27.9% | 3.48% | +11.9% |
| CNC | Sell | CENTENE CORP DEL | $61,822,000 | +1.0% | 750,270 | -23.6% | 3.36% | +27.3% |
| WOOF | Sell | PETCO HEALTH & WELLNESS CO I | $54,016,000 | -48.2% | 2,729,450 | -44.8% | 2.94% | -34.7% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $53,681,000 | -27.6% | 1,263,670 | -26.0% | 2.92% | -8.6% |
| DHR | New | DANAHER CORPORATION | $49,546,000 | – | 150,590 | +100.0% | 2.70% | – |
| JNJ | Buy | JOHNSON & JOHNSON | $47,867,000 | +3970.3% | 279,810 | +3743.5% | 2.60% | +5007.8% |
| ANTM | New | ANTHEM INC | $47,077,000 | – | 101,560 | +100.0% | 2.56% | – |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $44,473,000 | -25.9% | 349,080 | -24.2% | 2.42% | -6.5% |
| SYK | Sell | STRYKER CORPORATION | $42,504,000 | -27.6% | 158,940 | -28.6% | 2.31% | -8.6% |
| LIVN | Sell | LIVANOVA PLC | $37,647,000 | -27.1% | 430,600 | -34.0% | 2.05% | -8.0% |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $37,033,000 | -23.2% | 285,620 | -18.1% | 2.02% | -3.2% |
| XLV | New | SELECT SECTOR SPDR TRsbi healthcare | $35,818,000 | – | 254,230 | +100.0% | 1.95% | – |
| COO | New | COOPER COS INC | $33,570,000 | – | 80,130 | +100.0% | 1.83% | – |
| NVRO | Sell | NEVRO CORP | $33,176,000 | -46.1% | 409,230 | -22.7% | 1.80% | -32.1% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $32,923,000 | -40.5% | 2,377,130 | -38.2% | 1.79% | -24.9% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $31,150,000 | -27.1% | 365,737 | -17.9% | 1.70% | -8.1% |
| ABT | New | ABBOTT LABS | $28,529,000 | – | 202,710 | +100.0% | 1.55% | – |
| MDT | New | MEDTRONIC PLCcall | $28,449,000 | – | 275,000 | +100.0% | 1.55% | – |
| HUM | New | HUMANA INC | $25,345,000 | – | 54,640 | +100.0% | 1.38% | – |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $25,339,000 | +9.2% | 1,157,560 | -4.7% | 1.38% | +37.6% |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $23,661,000 | +941.9% | 1,449,835 | +1678.9% | 1.29% | +1214.3% |
| HCA | Sell | HCA HEALTHCARE INC | $21,651,000 | -62.4% | 84,270 | -64.5% | 1.18% | -52.6% |
| LGV | LONGVIEW ACQUISITION CORP II | $21,017,000 | -0.5% | 2,135,900 | 0.0% | 1.14% | +25.4% | |
| PFE | New | PFIZER INC | $20,024,000 | – | 339,110 | +100.0% | 1.09% | – |
| AVTR | New | AVANTOR INC | $18,052,000 | – | 428,380 | +100.0% | 0.98% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $17,885,000 | – | 28,320 | +100.0% | 0.97% | – |
| ABBV | New | ABBVIE INC | $16,945,000 | – | 125,150 | +100.0% | 0.92% | – |
| MCK | Sell | MCKESSON CORP | $15,926,000 | -81.9% | 64,070 | -85.5% | 0.87% | -77.2% |
| UNH | New | UNITEDHEALTH GROUP INC | $14,562,000 | – | 29,000 | +100.0% | 0.79% | – |
| CANO | Sell | CANO HEALTH INC | $14,138,000 | -59.5% | 1,586,720 | -42.4% | 0.77% | -49.0% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $14,076,000 | – | 159,320 | +100.0% | 0.77% | – |
| AMGN | New | AMGEN INC | $14,058,000 | – | 62,490 | +100.0% | 0.76% | – |
| RACB | RESEARCH ALLIANCE CORP II | $12,877,000 | -1.3% | 1,324,800 | 0.0% | 0.70% | +24.5% | |
| HSIC | New | HENRY SCHEIN INC | $9,894,000 | – | 127,610 | +100.0% | 0.54% | – |
| IMGN | Buy | IMMUNOGEN INC | $9,723,000 | +757.4% | 1,310,340 | +555.2% | 0.53% | +979.6% |
| AFMD | Sell | AFFIMED N V | $9,505,000 | -39.8% | 1,721,925 | -32.6% | 0.52% | -24.2% |
| CCXI | New | CHEMOCENTRYX INC | $8,758,000 | – | 240,530 | +100.0% | 0.48% | – |
| INCY | Buy | INCYTE CORP | $7,931,000 | +53.7% | 108,050 | +44.1% | 0.43% | +93.7% |
| RAPT | Sell | RAPT THERAPEUTICS INC | $6,663,000 | +16.2% | 181,400 | -1.8% | 0.36% | +47.0% |
| QTRX | New | QUANTERIX CORP | $5,696,000 | – | 134,340 | +100.0% | 0.31% | – |
| SGEN | New | SEAGEN INC | $5,239,000 | – | 33,890 | +100.0% | 0.28% | – |
| New | HYPERFINE INC | $5,014,000 | – | 691,650 | +100.0% | 0.27% | – | |
| VCYT | Buy | VERACYTE INC | $4,932,000 | +113.9% | 119,710 | +141.2% | 0.27% | +168.0% |
| ARYA SCIENCES ACQUISITN CORP | $4,850,000 | -1.8% | 500,000 | 0.0% | 0.26% | +23.9% | ||
| CYTK | Sell | CYTOKINETICS INC | $4,290,000 | -72.4% | 94,120 | -78.3% | 0.23% | -65.2% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $4,201,000 | -79.1% | 104,482 | -78.8% | 0.23% | -73.6% |
| STXS | New | STEREOTAXIS INC | $4,071,000 | – | 656,540 | +100.0% | 0.22% | – |
| INSP | New | INSPIRE MED SYS INC | $4,024,000 | – | 17,490 | +100.0% | 0.22% | – |
| IKNA | Sell | IKENA ONCOLOGY INC | $3,607,000 | -15.9% | 287,621 | -15.4% | 0.20% | +5.9% |
| MRUS | Buy | MERUS N V | $3,554,000 | +127.8% | 111,760 | +57.6% | 0.19% | +188.1% |
| LPTX | Sell | LEAP THERAPEUTICS INC | $3,456,000 | -28.2% | 1,066,689 | -11.1% | 0.19% | -9.6% |
| AXNX | New | AXONICS INC | $3,300,000 | – | 58,920 | +100.0% | 0.18% | – |
| New | PYXIS ONCOLOGY INC | $2,686,000 | – | 244,838 | +100.0% | 0.15% | – | |
| OHPA | Sell | ORION ACQUISITION CORP | $1,954,000 | -63.2% | 199,751 | -63.5% | 0.11% | -53.7% |
| Buy | DICE THERAPEUTICS INC | $1,893,000 | +35.0% | 74,774 | +74.7% | 0.10% | +71.7% | |
| LGVWS | LONGVIEW ACQUISITION CORP II*w exp 99/99/999 | $363,000 | -34.1% | 427,178 | 0.0% | 0.02% | -16.7% | |
| BBIO | New | BRIDGEBIO PHARMA INCcall | $167,000 | – | 10,000 | +100.0% | 0.01% | – |
| New | EQRX INC*w exp 12/17/202 | $107,000 | – | 99,998 | +100.0% | 0.01% | – | |
| OHPAW | ORION ACQUISITION CORP*w exp 02/19/202 | $89,000 | +1.1% | 137,305 | 0.0% | 0.01% | +25.0% | |
| MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $60,000 | +1.7% | 82,663 | 0.0% | 0.00% | 0.0% | |
| EUCRW | New | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $45,000 | – | 78,059 | +100.0% | 0.00% | – |
| CMLTW | Exit | CM LIFE SCIENCES III INC*w exp 04/30/202 | $0 | – | -99,998 | -100.0% | -0.01% | – |
| ATAI | Exit | ATAI LIFE SCIENCES NV | $0 | – | -75,000 | -100.0% | -0.05% | – |
| AVIR | Exit | ATEA PHARMACEUTICALS INC | $0 | – | -36,580 | -100.0% | -0.06% | – |
| JYAC | Exit | JIYA ACQUISITION CORP | $0 | – | -140,680 | -100.0% | -0.06% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -7,510 | -100.0% | -0.06% | – |
| Exit | PROCEPT BIOROBOTICS CORP | $0 | – | -37,400 | -100.0% | -0.06% | – | |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -9,890 | -100.0% | -0.08% | – |
| EUCRU | Exit | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $0 | – | -234,180 | -100.0% | -0.10% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -70,050 | -100.0% | -0.10% | – |
| SRSAU | Exit | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $0 | – | -262,150 | -100.0% | -0.11% | – |
| OMEG | Exit | OMEGA ALPHA SPACcl a | $0 | – | -271,032 | -100.0% | -0.11% | – |
| ABGI | Exit | ABG ACQUISITION CORP I | $0 | – | -329,400 | -100.0% | -0.14% | – |
| GHRS | Exit | GH RESEARCH PLCordinary shares | $0 | – | -164,912 | -100.0% | -0.16% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -23,690 | -100.0% | -0.28% | – |
| MSAC | Exit | MEDICUS SCIENCES ACQUISITION | $0 | – | -744,000 | -100.0% | -0.31% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -128,450 | -100.0% | -0.33% | – |
| EHC | Exit | ENCOMPASS HEALTH CORP | $0 | – | -119,600 | -100.0% | -0.39% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -82,183 | -100.0% | -0.49% | – |
| MRVI | Exit | MARAVAI LIFESCIENCES HLDGS I | $0 | – | -250,000 | -100.0% | -0.53% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -386,190 | -100.0% | -0.57% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -173,800 | -100.0% | -0.64% | – |
| ZTS | Exit | ZOETIS INCcl a | $0 | – | -83,060 | -100.0% | -0.70% | – |
| INCY | Exit | INCYTE CORPcall | $0 | – | -267,000 | -100.0% | -0.79% | – |
| IDXX | Exit | IDEXX LABS INC | $0 | – | -35,800 | -100.0% | -0.96% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -130,290 | -100.0% | -1.02% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -46,730 | -100.0% | -1.34% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -140,540 | -100.0% | -1.49% | – |
| VTR | Exit | VENTAS INC | $0 | – | -725,010 | -100.0% | -1.73% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -211,780 | -100.0% | -1.83% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -330,590 | -100.0% | -2.09% | – |
| WELL | Exit | WELLTOWER INC | $0 | – | -617,480 | -100.0% | -2.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.